Dossier
Amyloid plaques
Coverage of Amyloid plaques in the Nexus archive.
Alzheimer's Association Southwest & Rocky Mountain Regionorganization1Alzheimer's Association International Conferenceorganization1Alzheimer's Association of Coloradoorganization1Valerie Lombardiperson1National Institutes of Healthorganization1Alzheimer's Screening and Prevention Acttopic1p-tau217topic1tau tanglestopic1IDOLtopic1Alzheimer's diseasetopic1
- Blood test may predict risk of Alzheimer's disease a decade before symptoms, Alzheimer's Association finds
A blood test detecting p-tau217 may identify Alzheimer's disease risk a decade before symptoms, with 78% of symptom-free adults with high levels developing cognitive impairment in 10 years. Advocates seek Medicare coverage for the screening via the Alzheimer's Screening and Prevention Act.
- Scientists found a hidden Alzheimer’s trigger and shut it down
Researchers have identified a new enzyme called IDOL that contributes to Alzheimer's disease, and removing it from neurons improves brain processes and reduces amyloid plaques. This discovery may lead to future treatments that protect the brain from decline. The findings could potentially help develop new therapies beyond current treatments.